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Abstract 
Liver disorders are often associated with long chain polyunsaturated fatty acid deficiency due to hepatic insufficiency or lack of 
dietary intake that is hypothesized to further aggravate the condition. Consumption of diets rich in n-3 polyunsaturated fatty 
acids (PUFA) have been described to be beneficial against diets rich in saturated fatty acids (SFA) in various inflammatory 
disorders. Hence, we tested the hypothesis that the consumption of dietary fatty acids especially n-3PUFA is associated with 
the amelioration of hepatitis. We selected two sources of dietary fatty acids i.e. fish oil rich in n-3 PUFA  and meat oil rich in 
SFA. The diet preparation differed only in the type of the oil used. 10% fish oil or meat oil was freshly blended with the pellet 
diet and fed to the experimental mice for a period of 30 days. Hepatitis was induced in the experimental model i.e. mice (Mus 
musculus) by intraperitoneal injection of D-Galactosamine. Upon induction of hepatitis, the n-3 PUFA group showed elevated 
levels of total protein while maintaining thiobarbituric acid reactive substances and tocopherol unaltered. In contrast, the SFA 
group showed decreased level of total protein, reduced glutathione and tocopherol along with an augmentation of TBARS. 
Degree of augmentation of gamma glutamyl transpeptidase activity and bilirubin concentration upon induction of hepatitis were 
much lower in the fish oil supplemented groups compared to the control diet fed groups. In spite of induction of hepatitis, the n-
3 PUFA group showed well preserved liver architechture with no evidence of hemorrhage, necrosis or hepatocytolysis except 
mild inflammation. Our present findings indicate a significant alleviation of D-GaIN induced hepatitis by dietary n-3 
polyunsaturated fatty acids rich fish oil than that of meat oil.  
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Introduction 
Dietary fatty acids play an important role in various 
physiological processes and maintaining health. A 
large number of studies have shown positive health 
benefits associated with the consumption of n-3 
polyunsaturated fatty acids (PUFA) on infant 
development, cancer, cardiovascular diseases and 
various mental illnesses such as depression, attention 
deficit hyperactivity disorder and dementia [1].  On the 
other hand, a few studies have also suggested that the 
total dietary fat intake is linked to an increased risk of 
obesity and diabetes [2]. Diets high in saturated fatty 
acids (SFA) are correlated with an increased incidence 
of atherosclerosis and coronary diseases [3]. Thus, 
some of the most common medical disorders today like 
cardiovascular disease, hyperlipidemia, obesity, cancer 
etc. are characterized by the altered levels of fatty 
acids or their metabolites [4].  
Liver disorders are often associated with a long 
chain PUFA deficiency. The impaired PUFA status is 
mainly due to hepatocellular insufficiency. A low intake 
of dietary fat is suspected as another reason for a 
deficiency in plasma PUFAs [5]. The consumption of 
diets rich in n-3 PUFA has been described to be 
beneficial in cardiovascular disorders [6] rheumatoid 
arthritis [7] etc. Dietary PUFA have been shown to 
suppress proinflammatory cytokine production [8] and 
inhibit lymphocyte proliferation [9]. Cabre and Gassul 
[10] reported that habitual fish intake protects against 
hepatic encephalopathy. The objective of the present 
study was to test the hypothesis that the consumption 
of dietary fatty acids especially n-3PUFA is associated 
with the amelioration of hepatitis. We selected two 
sources of dietary fatty acids i.e. fish oil rich in n-3 
PUFA  and meat oil rich in SFA (Table1) for our 
present study. Hepatitis was induced by using D-
Galactosamine (D-GaIN) as it is very similar to human 
viral hepatitis. 
 
Materials and Methods 
This study was conducted in the animal house of 
department of Zoology, University of Goa, India.  Swiss 
albino mice, Mus musculus (Two months old) of 
uniform weight (22 ± 0.5 g) were selected for our 
present study. They were maintained in constant 
temperature, humidity, 12 hour light dark cycle and 
received humane care. After acclimatization for a 
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period of two weeks, experimental animals were 
divided into three different groups of (n=12). They were 
fed with the commercial pellet diet and water ad libitum.  
The experimental protocols and methods of animal 
maintenance were approved by Animal Ethics 
Committee of Goa University.  
Protocol of Experiments:  
Swiss albino mice were divided in to three groups 
(n=12). At the end of 30 days of feeding half the 
animals from each group received intraperitoneal 
saline injection (1ml of physiological saline) for two 
consecutive days and served as controls while the 
other half received intraperitoneal D-GaIN injection 
(0.5mg/g body wt /1ml of physiological saline) and 
served as liver injury models  [11]. 
Group 1. Served as control and received standard 
pellet diet and water ad libitum. This group was further 
subdivided into saline and GaIN groups depending 
upon the treatment they received. 
Group 2. Fish oil  at a dose of 10% freshly 
blended along with standard pellet diet was given for a 
period of 30 days. This group was further subdivided 
into saline and GaIN groups depending upon the 
treatment they received. 
Group 3. Meat oil at a dose of 10% freshly 
blended along with standard pellet diet was given for a 
period of 30 days. This group was further subdivided 
into saline and GaIN groups depending upon the 
treatment they received. 
 The composition of these two oils is as shown in 
Table 1.  Cages were cleaned the next day and 
checked for any left over food. During the entire period 
of our experimentation we found none or negligible 
amount of food left over.  Animals were starved for 10-
12h before sacrificing. Experimental animals were 
anesthetized to collect blood and liver samples for 
further analysis. 
Methods 
(A) Biochemical Tests: Albumin (using bromocresol 
green reagent), protein (using Lowry’s reagent), total 
and conjugated bilirubin (using Diazo reagent) were 
estimated by following routine analytical method [12].  
Thiobarbituric acid reactive substances were estimated 
by using TBA-TCA-HCl reagent following the method of 
Niehaus and Samuelsson [13].   Reduced glutathione 
was measured by using 5, 5’-Dithiobis, 2-nitrobenzoic 
acid [14].   Tocopherol and ascorbic acids were 
measured by using dipyridyl-ferric chloride reagent [15] 
and dinitrophenyl hydrazine reagent [12]   respectively.   
(B) Enzyme Tests: Alanine transaminase (ALT) [EC 
2.6.1.2] and aspartate transaminase [EC 2.6.1.1] (AST) 
activities were assayed by using dinitrophenyl 
hydrazine reagent [16]. Alkaline phosphatase (ALP) 
[EC 2.6.1.2] activity was assayed by using p-
nitrophenol reagent [17]. Gamma glutamyl 
transpeptidase (GGT) [E.C. 2.3.2.2] activity was 
measured by using glacial acetic acid reagent [18].    
(C) Histopathological Tests: Routine laboratory 
method was followed for histological studies. Liver 
tissues were perfused with phosphate buffer saline (pH 
7.0) and fixed in 10% formaline. The paraffin block was 
cut into uniform sections of 10μm thickness using a 
microtome and tissue sections were stained with 
hematoxylin and eosin for histopathological 
examination (40 X) under a polarizing microscope 
(Olympus BX41). 
Statistical Analysis: Analyses were performed using 
the Statistical Package for the Social Sciences, version 
7.5 (SPSS Inc, Chicago Ill). Differences between two 
groups were analyzed by independent samples student 
t test. Differences between various groups were 
analyzed by one way ANOVA. The level of significance 
was set to P< 0.05. 
 
Results 
Table 1:         Fatty acid composition of fish oil 
and meat oil. 
 
 
  
 
 
 
 
 
 
 
 
 
 
Dietary intake of fish oil for a period of 30 days 
was found to cause 35-40% elevation (P<0.001) in the 
total protein content including both albumin and 
globulin fractions in liver and serum. Meat oil diet 
elevated the serum total protein content (20%, P<0.001) 
only due to globulin fraction. It is revealed from table 2 
that induction of hepatitis in the control diet fed group 
(Cd) led to about 60% reduction (P<0.001) in the total 
protein including both albumin and globulin fractions. 
The total protein content remained unaltered in the fish 
Type of 
fatty acid 
Fish oil Meat 
oil 
14:0 
16:0 
18:0 
20:0 
11.62 
23.27 
5.76 
0.86 
 8.97 
32.88 
26.31 
 1.57 
18:1 
20:1 
22:1 
11.90 
10.69 
  0.12 
  1.52 
12.55 
  0.35 
18:2n6 
20:2n6 
20:4n6 
3.13 
0.16 
1.73 
9.25 
0.32 
4.17 
18:3n3 
20:5n3 
22:5n3 
22:6n3 
  0.21 
17.86 
  1.83 
10.86 
0.10 
0.52 
0.12 
1.37 
Sat/Unsat 
ratio 
0.709 2.304 
n-3 /n-6 6.127 0.154 
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oil supplemented group upon D-GaIN administration 
(Fd). On the other hand, induction of hepatitis in the 
meat oil supplemented group of mice (Md) caused a 
significant decrease in the total protein content 
including both albumin and globulin fractions in liver 
tissue while it did not show any major changes in the 
serum protein levels. 
Dietary lipid intake led to an elevation in ascorbic 
acid (2-5 fold, P<0.001), tocopherol (10-15%, P<0.001) 
and GSH (15-60%, P<0.001) while it lowered TBARS 
(15-25%, P<0.001) (Fig. 1). D-GaIN administration in 
the control diet fed Cd group caused depletion of 
ascorbic acid (20-30%, P<0.0001), tocopherol (35%, 
P<0.0001) and GSH (45-50%, P< 0.0001) while 
leading to a significant 1.5 fold elevation in the TBARS 
(Figure2). Dietary lipid intake maintained higher levels 
(50% to 3 fold, P<0.0001) of ascorbic acid in both liver 
and serum in spite of induction of hepatitis (Fig 3). Fd 
group of mice maintained the tocopherol and TBARS 
unaltered in both liver and serum. However, Md groups 
had significantly higher levels of TBARS (60% to 2 fold), 
lower levels of tocopherol (20 -25%) and GSH (10-
30%). 
 
Table 2: Effect of dietary fatty acids on albumin and globulin fractions of protein upon D-GaIN induced hepatitis 
in mice, Mus musculus. Data are represented as mean of six values ± SE. 
 
              
 
 
                
 
 
 
 
 
 
 
 
 
 
 
Table 3: Effect of dietary fatty acids on enzyme activities upon D-GaIN induced hepatitis in mice, Mus musculus. 
Data are represented as mean of six values ± SE. 
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           Table 4:  Effect of dietary fatty acids on total and conjugated bilirubin concentration upon D-GaIN induced   
                              hepatitis in mice, Mus musculus. Data are represented as mean of six values ± SE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1:   Effect of supplementation of dietary lipids on various parameters like   Ascorbic acid (μmol), tocopherol (nmol x10), 
reduced glutathione (μmol), TBARS (nmol  MDA) of mice, Mus musculus. Mice were fed ad libitum with  commercial pellet 
diet supplemented with 10% fish oil or meat oil for 30  days. Cs (without lipid supplementation); Fs (supplemented with fish 
oil); Ms (with meat oil  supplementation). All these mice received 1 ml of physiological saline for two  days.   Values are mean 
± SE of six oservations.  All the changes were significant (P<0.05) compared to the Cs group. 
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Figure 2 : Effect of D-GaIN induced hepatitis on various parameters like   ascorbic acid (μmol), tocopherol (nmol 
x10), reduced glutathione (μmol),  TBARS (nmol MDA) in mice, Mus musculus. Cs (without any lipid 
supplementation and received 1ml physiological saline injection for two  subsequent days); Cd (without any lipid 
supplementation and received 5mg D- GaIN/ g body wt /animal in 1ml  physiological saline injection  for two 
consecutive  days). Values are mean ± SE of six oservations. All changes were   significant (P<0.05) compared to 
the Cs group. 
 
Dietary intake of fish and meat oil significantly 
brought down the activity of ALT by 5-15% (P<0.05) in 
liver and AST activity by 20-30% (P<0.05) in both liver 
and serum. Both the diets did not affect ALP activity 
either in liver tissue or in serum (Table 3). No 
significant changes in the GGT activity were noticed 
upon fish or meat oil intake. Induction of hepatitis 
markedly increased the activity of AST and ALT by 
60%- 2 fold (P<0.001) in Cd group. It caused about 50-
75% (P<0.001) elevation in ALP activity and about 2.5 
fold (P<0.0001) increase of GGT activity in Cd group.  
Fd group showed only about 15% elevation in the liver 
ALP activity while maintaining it unaltered in serum 
where as the Md group showed 20-40% elevation in its 
activity. We observed 25-60% elevation (P<0.0001) in 
the GGT activity in both Fd and Md groups of mice, 
however the degree of augmentation was much lower 
compared to the Cd group.  
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Figure 3: Effect of supplementation of dietary lipids in D-GaIN injected mice Mus musculus. on various 
parameters like   ascorbic acid (μmol), tocopherol (nmol x10), reduced glutathione (μmol), TBARS  (nmol MDA).   
Fd (with 10% fish oil supplementation for one month prior to D-GaIN injection); Md  (with 10%  meat  oil 
supplementation prior to D-GaIN injection at a  dose of  5mg/ g body wt /animal  in 1ml  physiological  saline 
injection for two subsequent days). Values are mean ± SE of six oservations.  All changes other than*  were  
significant (P <0.05) compared to Cs. group.   
 
It can be noticed from Table 4 that dietary intake 
of both fish and meat oil for a period of 30 days, 
maintained the bilirubin levels unaltered. Induction of 
hepatitis led to a marked increase in the total and 
conjugated bilirubin concentration in liver and serum 
(6-15 fold P<0.001). Dietary lipid supplemented groups 
also showed 3-5 fold increase (P<0.001) in the bilirubin 
concentration however the degree of augmentation 
was much lower compared to the Cd group.          
Figure 4a revealed the normal histology of liver 
consisting of hepatic lobules, central vein and portal 
triad in the Cs group. Almost normal architecture of 
liver along with mild fatty changes was noticed in fish 
oil supplemented Fs group (Fig 4c).Dietary intake of 
meat oil caused fatty degeneration and mild 
inflammation in liver architecture where, abundant 
vacuolated foamy cytoplasm was seen (Fig 4e). D-
GaIN administration caused complete distortion of 
normal liver histology with severe degenerating 
changes in the Cd group (Fig 4b). Md group showed 
severe damages due to D-GaIN administration as was 
evident by the inflammatory and fatty changes (Fig 4f). 
However, we found alleviation of D-GaIN effect in the 
Fd group of mice where, the normal architecture of liver 
tissue was completely well preserved with no evidence 
of hemorrhage, necrosis or hepatocytolysis except mild 
inflammation (Fig 4d).  
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Figure 4 : Effect of dietary lipid supplementation  on the liver architecture of mice Mus musculus. a: mice 
without supplementation of lipid and received saline injection; b:  mice without supplementation of lipid and 
received  D-GaIN injection; c: mice with 10% fish oil  supplementation  and received saline injection; d: mice 
with 10% fish oil supplementation  and received D- GaIN injection;  e: mice with 10% meat oil supplementation  
and received saline injection; f: mice with 10% meat oil supplementation  and received D- GaIN injection; CV- 
Central Vein; H-Hepatocytes; HA-Haemorrhagic area; I I –Inflammatory Infilterate; MFD-Mild Fatty 
Degeneration ; CCV-Congestion of central vein; DH-Derangement of Hepatocytes ; FD-Fatty Degeneration 
 
Discussion  
The main finding of this study was a remarkable 
degree of amelioration of D-GaIN induced hepatitis 
associated with the dietary intake of n-3 PUFA rich 
diets as compared to the SFA rich diets. Previous 
findings have shown that a long chain PUFA deficiency 
is often observed with various liver disorders [19]. 
Hepatocellular insufficiency or a low intake of fat can 
lead to the deficiency in plasma PUFAs [20]. We made 
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use of fish oil and meat oil as the sources of dietary 
lipids which are rich in unsaturated or saturated fatty 
acids and also have different MUFA and PUFA 
compositions (Table1). D-GaIN induced hepatitis is 
used as an experimental model for being very similar to 
human viral hepatitis in its structural and morphological 
appearance [21].   
D-GaIN administration in the control diet fed group 
led to a marked decrease of about   60% (P<0.001)  in 
total protein including  albumin and globulin fractions  
(Table2) and 6-15 fold increase in bilirubin 
concentration suggesting a severe liver damage. This 
may be due to an increased protein catabolism or 
suppression of protein synthesis leading towards 
hepatotoxicity.   Sun et al. [22] have reported that a 
high dose of D-GaIN causes haemorrhage due to UTP 
depletion and inhibition of protein synthesis.   Within 30 
minutes of D-GaIN administration a large number of 
UTP derived metabolites accumulate leading to the 
depletion of hepatic UTP and inhibition of 
macromolecular biosynthesis of RNA, protein, 
glycogen etc [23].  About 20-35% reduction (P<0.001) 
in the antioxidant level  and 40-45% reduction 
(P<0.0001) in GSH level along with a marked increase 
in TBARS (Fig 2) due to D-GaIN administration was 
observed in the control diet fed group of mice. Sandhir 
and Gill [24] reported a similar kind of reduction in GSH 
in rats exposed to ethanol.  A marked increase (2.5fold) 
in the liver function tests and   GGT activity in the 
control diet fed group confirmed hepatic damage. ALT 
and AST are cytoplasmic in location and are released 
into the circulation after cellular damage [25].  
Increased activity of ALP can be due to the disturbance 
in secretory activity or the transport of metabolites [26]. 
Gamma glutamyl transpeptidase enzyme is most 
sensitive indicator of liver disease and a number of 
chemicals are known to increase its activity by the 
induction of microsomal enzyme [27]. This may be due 
to the fact that the depletion of GSH may induce 
hepatic GGT activity through an increased synthesis of 
its mRNA [28]. It is clear from table 2 that D-GaIN 
administration in the control diet fed group led to GSH 
depletion.  
Dietary intake of fish oil enhanced total protein 
(40%, P<0.001) including albumin and globulin 
fractions (Table2) in Mus musculus.  Dietary lipid intake 
enhanced antioxidant levels, decreased TBARS (Fig 1). 
Both Fd and Md  groups showed a significant elevation 
(25-60%, P<0.001) in the GGT activity in liver and 
serum however, the degree of augmentation was much 
lower compared to the induction of hepatitis in control 
diet fed group indicating  a better functioning of liver, 
more particularly with that of fish oil intake. 
 
Dietary intake of fish oil maintained elevated levels 
of protein, ascorbic acid without any alteration in the 
levels of TBARS and tocopherol upon D-GaIN 
administration.   In contrast, intake of  meat oil brought 
about 60% decrease (P<0.0001) in the liver total 
protein, while  maintaining higher levels of ascorbic 
acid (Figure 3) upon D-GaIN administration. Md group 
of mice also showed higher levels of TBARS which 
may indicate peroxidation of fatty acids upon D-GaIN 
administration. Dietary intake of lipids reduced any 
changes in GGT activity upon induction of hepatitis 
(Table 3). The hepatic damage caused by D-GaIN like 
ballooning, congestion or inflammatory infiltrations 
were lowered with the dietary intake of n-3 PUFA rich 
fish oil.  
Conclusion  
Our present findings indicated a remarkable 
alleviation of D-GaIN induced hepatitis with the dietary 
intake of n-3 PUFA rich fish oil than that of meat oil. 
Though meat oil also has MUFA and PUFA of ω-6 
series their beneficial effects might be counteracted by 
the presence of high levels of other SFAs unlike fish oil 
which has a very low level of SFAs. The 
hepatoprotective effects of fish oil might be due to 
eicosanoid dependent or eicosanoid independent i.e. 
cytokine regulatory actions which need further 
investigation.  
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